BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28765944)

  • 21. The c-MYC-AP4-p21 cascade.
    Jung P; Hermeking H
    Cell Cycle; 2009 Apr; 8(7):982-9. PubMed ID: 19270520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy.
    Tonelli R; McIntyre A; Camerin C; Walters ZS; Di Leo K; Selfe J; Purgato S; Missiaglia E; Tortori A; Renshaw J; Astolfi A; Taylor KR; Serravalle S; Bishop R; Nanni C; Valentijn LJ; Faccini A; Leuschner I; Formica S; Reis-Filho JS; Ambrosini V; Thway K; Franzoni M; Summersgill B; Marchelli R; Hrelia P; Cantelli-Forti G; Fanti S; Corradini R; Pession A; Shipley J
    Clin Cancer Res; 2012 Feb; 18(3):796-807. PubMed ID: 22065083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response.
    Madapura HS; Salamon D; Wiman KG; Lain S; Klein E; Nagy N
    Cell Cycle; 2016 May; 15(9):1267-75. PubMed ID: 26985633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
    Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BAG2 is a target of the c-Myc gene and is involved in cellular senescence via the p21(CIP1) pathway.
    Zhang J; Lou X; Yang S; He S; Yang L; Liu M; Zhu H; Shan Q; Su S; Zhan Q; Xu N; Liu S
    Cancer Lett; 2012 May; 318(1):34-41. PubMed ID: 22146591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A; Millington M; Sun LQ; Symonds G
    Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Coordination inhibition of the proliferation of MCF-7 by enhancing expression of p53,p21 and decreasing expression of c-myc].
    Zhang HJ; Wang N; Zhu XY; Sang JL; He DC
    Shi Yan Sheng Wu Xue Bao; 2005 Feb; 38(1):16-22. PubMed ID: 15839202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
    Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
    Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Δ133p53 mRNA in lung carcinoma corresponds with reduction of p21 expression.
    Fragou A; Tzimagiorgis G; Karageorgopoulos C; Barbetakis N; Lazopoulos A; Papaioannou M; Haitoglou C; Kouidou S
    Mol Med Rep; 2017 Apr; 15(4):1455-1460. PubMed ID: 28260096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosensitizing effects of c‑myc gene knockdown‑induced G2/M phase arrest by intrinsic stimuli via the mitochondrial signaling pathway.
    Fan Y; Jia X; Xie T; Zhu L; He F
    Oncol Rep; 2020 Dec; 44(6):2669-2677. PubMed ID: 33125136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21.
    Liu L; Xu F; Chang CK; He Q; Wu LY; Zhang Z; Li X
    Cell Death Dis; 2017 Oct; 8(10):e3126. PubMed ID: 29022893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.
    Miyachi M; Kakazu N; Yagyu S; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tsuchiya K; Iehara T; Hosoi H
    Clin Cancer Res; 2009 Jun; 15(12):4077-84. PubMed ID: 19509161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
    Mitchell KO; El-Deiry WS
    Cell Growth Differ; 1999 Apr; 10(4):223-30. PubMed ID: 10319992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PIK3CD promoted proliferation in diffuse large B cell lymphoma through upregulation of c-myc.
    Cui W; Zheng S; Li X; Ma Y; Sang W; Liu M; Zhang W; Zhou X
    Tumour Biol; 2016 Sep; 37(9):12767-12777. PubMed ID: 27448819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.
    Masuo T; Okamura S; Zhang Y; Mori M
    Cancer Lett; 2009 Nov; 285(1):66-72. PubMed ID: 19481339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.
    Abdou AG; Abd-Elwahed M; Badr M; Helmy M; Soliman EA; Maher D
    Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):75-87. PubMed ID: 25710583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DEK proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
    Feng T; Liu Y; Li C; Li Z; Cai H
    Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BimEL-dependent apoptosis induced in peripheral blood lymphocytes with n-butyric acid is moderated by variation in expression of c-myc and p21(WAF1).
    Kalousek I; Brodska B; Otevrelova P; Röselova P
    Cell Biochem Funct; 2008 Jun; 26(4):509-21. PubMed ID: 18348176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.